Support for life after treatment — science‑driven & patient‑centered.
Cancer treatment ends, but its effects often continue. Our survivorship care focuses on the physical and cognitive challenges that can linger after treatment. This includes neuropathy, “chemo brain,” sleep disruption, fatigue, and stress.
My work in survivorship is grounded in my clinical research. I bring my own findings into care, including biomarkers for treatment‑related symptoms, protocol design, and individualized treatment planning. This means you receive approaches that often take years to reach standard clinical settings.
Neuromodulation can be integrated to support pain modulation, attention, memory, mood, and overall regulation. Treatment plans are tailored to your goals and paced in a way that feels manageable and supportive.
Common areas of focus:
-
Neuropathy (tingling, burning, numbness, balance changes)
-
Cancer‑ or treatment‑related pain
-
Other pain conditions such as CPRS and post-operative pain
-
Cognitive changes (“chemo brain”)
Why This Approach Is Different
-
Research‑informed care using biomarkers and protocol design
-
Access to emerging neuroscience years before standard adoption
-
Clear, individualized treatment planning
-
Warm, relational support throughout the process
Why This Approach Is Different
-
Research‑informed care using biomarkers and protocol design
-
Access to emerging neuroscience years before standard adoption
-
Neuromodulation integrated when appropriate
-
Clear, individualized treatment planning
-
Warm, relational support throughout the process
Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Chemotherapy‑Induced Peripheral Neuropathy (CIPN) happens when certain cancer treatments irritate or damage the nerves that help you feel touch, temperature, and pain. When those nerves aren’t working well, people may notice tingling, numbness, burning, or discomfort in their hands and feet. CIPN affects both the nerves themselves and the way the brain interprets those signals. There are various remedies and treatments aimed at easing CIPN symptoms, but only a few have strong scientific support:
● Medications: Can reduce nerve‑related pain by adjusting how nerves send signals.
● Invasive neuromodulation: An implanted device that interrupts pain signals; involves a minor procedure.
● Non‑invasive neuromodulation: Gentle external stimulation or brain‑training exercises that help the nervous system handle sensory signals more comfortably thereby easing the perception of pain.
Our work has always focused on carefully measuring how each intervention affects the nervous system, and we know that every person’s experience is unique. That’s why we develop personalized, multifactorial plans tailored to your specific needs. If you’d like to explore what approach may best support your needs, book a free 15‑minute consultation.
Other Pain Conditions
Our approach is not limited to chemotherapy‑induced neuropathy. The same principles: precise measurement, nervous‑system‑focused methods, and personalized, multifactorial planning, can also support a range of other chronic pain and sensory conditions. Common areas we work with include:
-
Diabetic or metabolic neuropathy
-
Post‑surgical or post‑radiation nerve pain
-
Complex Regional Pain Syndrome (CRPS)
-
Persistent nerve pain after injury
Across these conditions, the nervous system plays a central role in how pain signals are generated and interpreted. By understanding how your sensory pathways and brain networks are functioning, we can identify strategies that help reduce discomfort and support daily functioning.
References
[1] Prinsloo S, Kaptchuk TJ, De Ridder D, Lyle R, Bruera E, Novy D, Barcenas CH, Cohen LG. Brain-computer interface relieves chronic chemotherapy-induced peripheral neuropathy: A randomized, double-blind, placebo-controlled trial. Cancer. 2024 Jan;130(2):300-311. doi: 10.1002/cncr.35027. Epub 2023 Sep 21. PMID: 37733286. https://pubmed.ncbi.nlm.nih.gov/37733286/
[2] Prinsloo S, Novy D, Driver L, Lyle R, Ramondetta L, Eng C, Lopez G, Li Y, Cohen L. The Long-Term Impact of Neurofeedback on Symptom Burden and Interference in Patients With Chronic Chemotherapy-Induced Neuropathy: Analysis of a Randomized Controlled Trial. J Pain Symptom Manage. 2018 May;55(5):1276-1285. doi: 10.1016/j.jpainsymman.2018.01.010. Epub 2018 Feb 5. PMID: 29421164. https://pubmed.ncbi.nlm.nih.gov/29421164/
[3] Prinsloo S, Gabel S, Lyle R, Cohen L. Neuromodulation of cancer pain. Integr Cancer Ther. 2014 Jan;13(1):30-7. doi: 10.1177/1534735413477193. Epub 2013 Feb 25. PMID: 23439659. https://pubmed.ncbi.nlm.nih.gov/23439659/
[4] Mulholland, M.M., Prinsloo, S., Kvale, E. et al. Behavioral and biologic characteristics of cancer-related cognitive impairment biotypes. Brain Imaging and Behavior 17, 320–328 (2023). https://doi.org/10.1007/s11682-023-00774-6
[5] Kesler SR, Henneghan AM, Prinsloo S, Palesh O and Wintermark M (2023) Neuroimaging based biotypes for precision diagnosis and prognosis in cancer-related cognitive impairment. Front. Med. 10:1199605. https://doi.org/10.3389/fmed.2023.1199605
Content reviewed by: Dr Sarah Prinsloo, PhD
Last Updated: July 2026